Rohypnol â contâd. Rohypnol Overview RohypnolÂ® is a trade name for flunitrazepam, a central nervous system (CNS) depressant that belongs to a class of drugs known as benzodiazepines. Flunitrazepam is also marketed as generic preparations and other trade name products outside of the United States.
(May 2013). An adverse event (AE) is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment.
Adverse media or negative news is defined as any kind of unfavorable information and can be found across a wide variety of sources â not only more âtraditionalâ news outlets. The risks associated with conducting business with persons or companies having an adverse media profile are many and varied.